Submission Details
| 510(k) Number | K221104 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 14, 2022 |
| Decision Date | August 04, 2022 |
| Days to Decision | 112 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K221104 is an FDA 510(k) clearance for the Actera? hip system, a Prosthesis, Hip, Semi-constrained, Uncemented, Metal / Polymer, Non-porous, Calcium Phosphate (Class II — Special Controls, product code MEH), submitted by Conformis, Inc. (Billerica, US). The FDA issued a Cleared decision on August 4, 2022, 112 days after receiving the submission on April 14, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3353.
| 510(k) Number | K221104 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 14, 2022 |
| Decision Date | August 04, 2022 |
| Days to Decision | 112 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MEH — Prosthesis, Hip, Semi-constrained, Uncemented, Metal / Polymer, Non-porous, Calcium Phosphate |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3353 |